NuWave Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,675
Closed -$953K 283
2022
Q2
$953K Buy
4,675
+239
+5% +$48.9K 1.27% 9
2022
Q1
$934K Buy
4,436
+605
+16% +$132K 1.25% 13
2021
Q4
$919K Sell
3,831
-446
-10% -$115K 1.04% 16
2021
Q3
$1.21M Buy
4,277
+3,318
+346% +$1.09M 1.38% 8
2021
Q2
$332K Buy
+959
New +$291K 0.37% 82
2021
Q1
Sell
-1,966
Closed -$481K 286
2020
Q4
$481K Buy
1,966
+1,672
+569% +$431K 0.63% 42
2020
Q3
$83K Sell
294
-4,667
-94% -$1.3M 0.13% 196
2020
Q2
$1.5M Buy
4,961
+4,862
+4,911% +$1.46M 1.97% 7
2020
Q1
$31K Sell
99
-1,157
-92% -$351K 0.07% 157
2019
Q4
$373K Buy
1,256
+1,209
+2,572% +$335K 0.36% 103
2019
Q3
$10K Sell
47
-2,147
-98% -$500K 0.01% 353
2019
Q2
$513K Buy
2,194
+2,168
+8,338% +$501K 0.54% 62
2019
Q1
$6K Buy
+26
New +$8.19K 0.01% 312
2018
Q4
Sell
-782
Closed -$276K 399
2018
Q3
$276K Buy
782
+781
+78,100% +$269K 0.42% 101
2018
Q2
$0 Buy
+1
New +$281 ﹤0.01% 383
2018
Q1
Sell
-1,494
Closed -$476K 238
2017
Q4
$476K Buy
+1,494
New +$479K 0.56% 69
2014
Q3
Sell
-199
Closed -$63K 287
2014
Q2
$63K Buy
199
+171
+611% +$51.5K 0.16% 165
2014
Q1
$9K Sell
28
-3,606
-99% -$1.14M 0.03% 229
2013
Q4
$1.02M Buy
3,634
+3,581
+6,757% +$926K 0.9% 31
2013
Q3
$13K Buy
53
+19
+56% +$4.25K 0.01% 238
2013
Q2
$7K Buy
+34
New +$7.26K 0.01% 269

Other funds holding BIIB

NuWave Investment Management's BIIB Position: Q3 2022 in Review

NuWave Investment Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 4,675 shares — an estimated $953K sold.

NuWave Investment Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $1.5M in Q2 2020. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • NuWave Investment Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • NuWave Investment Management sold 4,675 Biogen shares in Q3 2022, an estimated $953K.
  • NuWave Investment Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
  • NuWave Investment Management's Biogen position peaked at $1.5M in Q2 2020.
  • 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.